Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort

doi:10.3748/wjg.v23.i14.2545

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (13560)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-4) series, Tables (1-2) series.

Item

Count

PDF

756

WORD

498

HTML

8639

Figures (1-4)

438

Tables (1-2)

305

Sum=10636

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1289

Download

1633

Sum=2922

Apr 14, 2017 (publication date) through Feb 27, 2025

Times Cited of This Article

Times Cited (18)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Apr 14, 2017; 23(14): 2545-2555
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2545

Full Size Figure Download Figure

Figure 1 Flow diagram shows the patient selection criteria. BCLC: Barcelona Clinic Liver Cancer; HCC: Hepatocellular carcinoma; PS: Performance status; TACE: Trans arterial chemoembolization.

Citation: Adhoute X, Pénaranda G, Raoul JL, Edeline J, Blanc JF, Pol B, Campanile M, Perrier H, Bayle O, Monnet O, Beaurain P, Muller C, Castellani P, Le Treut YP, Bronowicki JP, Bourlière M. Barcelona clinic liver cancer nomogram and others staging/scoring systems in a French hepatocellular carcinoma cohort. World J Gastroenterol 2017; 23(14): 2545-2555
URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2545.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2545